This site uses cookies to bring you the best experience. Find out more
Skip to main content
↑

News

Find Out The Latest

Keep in touch with exciting developments from The Oxford Science Park and its occupiers here.

Contact us on comms@oxfordsp.com if you would like to know more about any of these stories.

You can also follow us on LinkedIn  

First production and administration of Axumin (fluciclovine (18F)) in France

First production and administration of Axumin (fluciclovine (18F)) in France

12 Dec 2018

First production and administration of Axumin (fluciclovine (18F)) in France. Oxford, UK – December 12, 2018 – Blue Earth Diagnostics, a leading molecular imaging diagnostics company, today announced that the first commercial production of Axumin® (fluciclovine (18F)) in France occurred recently, with the first French patients being dosed. Axumin is a novel molecular imaging agent approved in the European Union for use in PET... Read more

Leading AI-driven drug discovery company Exscientia expands to The Oxford Science Park

Leading AI-driven drug discovery company Exscientia expands to The Oxford Science Park

01 Nov 2018

Facilities in The Schrödinger Building to bring together AI experts and biologists. Oxford, UK, 1 November 2018 – In a key point in its growth strategy, Exscientia, the innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, is expanding its Oxford presence to the new Schrödinger Building on The Oxford Science Park, one of the UK’s leading parks for science and technology companies. In its new facilities,... Read more

Blue Earth Diagnostics wins prestigious ‘Best Emerging Biotech’ award

Blue Earth Diagnostics wins prestigious ‘Best Emerging Biotech’ award

12 Oct 2018

Oxford, UK – October 12, 2018 – Blue Earth Diagnostics, a leading molecular imaging diagnostics company, has won  the Oxford Bio Network (OBN) award for “Best Emerging Biotech ”.  These prestigious OBN awards, which are judged by a panel of leading industry entrepreneurs and experts, celebrate innovation and outstanding achievement across the UK’s Life Sciences industry. The OBN’s “Best Emerging Biotech ” award goes... Read more

Blue Earth Diagnostics shortlisted for prestigious ‘Best Emerging Biotech Company’ award

Blue Earth Diagnostics shortlisted for prestigious ‘Best Emerging Biotech Company’ award

09 Aug 2018

Oxford, UK – August 9, 2018 – Blue Earth Diagnostics, a leading molecular imaging diagnostics company, yesterday announced that it has been shortlisted as a finalist in the 2018 OBN awards in the category “Best Emerging Biotech Company”. These prestigious awards, which are judged by a panel of leading industry entrepreneurs and experts, celebrate innovation and outstanding achievement across the UK’s Life Sciences industry.... Read more

South Oxfordshire Science Village steams ahead

South Oxfordshire Science Village steams ahead

03 Aug 2018

Plans for the South Oxford Science Village, a mixed community of high tech business space, around 3,000 homes, schools and infrastructure on the southern border of Oxford, received a boost in November 2017 when the National Infrastructure Commission report on the Oxford – Milton Keynes – Cambridge Arc (Partnering for Prosperity) recommended the re-opening of the Cowley Branch Line to passenger services by 2019.  This proposal was echoed by... Read more

The Daubeny Project

Imaginative design, inspiring spaces.

450,000 sq ft of
premium lab space
completing 2026

Discover More